微谱生物科技是微谱科技集团在生物药领域的重要战略布局，微谱生物科技立足于生物医药全产业链，依托创新型自主知识产权体系构建出成熟的服务矩阵，致力于为国内外生物药企业提供合规、专业、一体化的生物制品质量与安全研究综合解决方案，拥有成功项目经验500个。目前，我们的实验室已经成功通过美国FDA官方现场检查。未来，微谱生物科技还将继续接轨全球生物药企业需求，专注打造国际合规的质量与安全检测平台，全力支持客户高效推进中美欧等项目多报。

WEIPU Biotech is a key strategic division of WEIPU Technology Group within the biopharmaceutical sector. Grounded in the full industry chain of biopharma, WEIPU Biotech has established a mature service matrix supported by an innovative independent intellectual property system. We are committed to providing compliant, professional, and integrated comprehensive solutions for biologics quality and safety research to biopharmaceutical companies both domestically and internationally, with over 500 successful project experiences to date.

Our laboratories have successfully passed official on-site inspections conducted by the U.S. FDA. Moving forward, WEIPU Biotech will continue to align with the needs of global biopharmaceutical enterprises, focusing on building an internationally compliant quality and safety testing platform. We are dedicated to fully supporting our clients in efficiently advancing multi-regional submissions for projects in markets such as China, the United States, and Europe.